NanoSHIFT LLC   Report issue

For profit Phase 2
Founded: Emeryville CA United States (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2009
NCT00764361
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

doxycycline (vibramycin) (3 trials)

ntc-510 (1 trial)

Drugs in Other Trials (2)

buprenorphine (2 trials)

naloxone (narcan) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 2)

Foot Ulcer (Phase 2)

Leg Ulcer (Phase 2)

Toothache (Phase 2)

Ulcer (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 4